ABIOMED Inc (NASDAQ:ABMD)

278.58
Delayed Data
As of Oct 22
 +5.90 / +2.16%
Today’s Change
119.01
Today|||52-Week Range
319.19
+63.31%
Year-to-Date
Analysts Estimate Abiomed (ABMD) to Report a Decline in Earnings: What to Look Out for
Oct 22 / Zacks.com - Paid Partner Content
IART vs. ABMD: Which Stock Is the Better Value Option?
Oct 14 / Zacks.com - Paid Partner Content
3 Stocks Growing Capex Fast
Oct 18 / GuruFocus News - Paid Partner Content
3 Safe Stocks for a Coming Market Crash
Oct 13 / MotleyFool.com - Paid Partner Content
Abiomed's Heart Pump Can Improve Outcomes in Some Patients
Oct 15 / MotleyFool.com - Paid Partner Content
This Medical Device Player Could Be a Top-Notch Pick in 2020
Oct 10 / MotleyFool.com - Paid Partner Content
Is Abiomed Stock a Buy?
Oct 15 / MotleyFool.com - Paid Partner Content
This Under-the-Radar Company May Be the Safest Coronavirus Stock to Buy
Oct 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close272.60
Today’s open273.05
Day’s range270.62 - 278.67
Volume292,447
Average volume (3 months)336,803
Market cap$12.9B
Data as of 4:00pm ET, 10/22/2020

Growth & Valuation

Earnings growth (last year)-22.09%
Earnings growth (this year)+1.04%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+9.29%
P/E ratio80.1
Price/Sales7.91
Price/Book12.10

Competitors

 Today’s
change
Today’s
% change
PODDInsulet Corp+4.11+1.70%
PENPenumbra Inc+0.05+0.02%
TFXTeleflex Inc+0.31+0.08%
----
Data as of 4:00pm ET, 10/22/2020

Financials

Next reporting dateOctober 29, 2020
EPS forecast (this quarter)$0.91
Annual revenue (last year)$840.9M
Annual profit (last year)$203.0M
Net profit margin24.14%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Danvers, Massachusetts

Forecasts